about
Vitreous mediators in retinal hypoxic diseasesUnilateral amblyopia: An optical coherence tomography study.Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics.Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.Age related macular degeneration and visual disability.Pars plana vitrectomy for the repair of primary, inferior rhegmatogenous retinal detachment associated to inferior breaks. A comparison of a 25-gauge versus a 20-gauge systemEffect of palmitoylethanolamide on visual field damage progression in normal tension glaucoma patients: results of an open-label six-month follow-up.Short-time prone posturing is well-tolerated and reduces the rate of unintentional retinal displacement in elderly patients operated on for retinal detachment.Silicone oil removal after rhegmatogenous retinal detachment: comparing techniques.Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study.TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathyMultiple evanescent white dot syndrome (MEWDS).Myopia onset and progression: can it be prevented?Topical nonsteroidal anti-inflammatory drugs for macular edema.Diabetic Retinopathy: Vascular and Inflammatory Disease.Iatrogenic retinal breaks in ultrahigh-speed 25-gauge vitrectomy: a prospective study of elective cases.Some physicochemical remarks on spontaneous emulsification of vitreal tamponades.Natural evolution of fundus autofluorescence findings in multiple evanescent white dot syndrome: a long-term follow-up.Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy.Presumed idiopathic outer lamellar defects of the fovea and chronic solar retinopathy: an OCT and fundus autofluorescence study.Response to Wong et al.Toxoplasma gondii: an atypical presentation of toxoplasma as optic disc swelling and hemispherical retinal vein occlusion treated with intravitreal clindamycin.Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation.Multimodal Approach to Monitoring and Investigating Cone Structure and Function in an Inherited Macular Dystrophy.Early simultaneous fundus autofluorescence and optical coherence tomography features after pars plana vitrectomy for primary rhegmatogenous retinal detachment.Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injectionBilateral isolated acute cataracts in three newly diagnosed insulin dependent diabetes mellitus young patientsAcute juvenile cataract in newly diagnosed type 1 diabetic patients: a description of six casesLongitudinal study of macular folds by spectral-domain optical coherence tomographyEvolution of outer retinal folds occurring after vitrectomy for retinal detachment repairEffect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisationSerum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathyMetamorphopsia and optical coherence tomography findings after rhegmatogenous retinal detachment surgeryLamellar macular holes in the eyes with pathological myopiaConfocal microscopy of corneal nerve plexus as an early marker of eye involvement in patients with type 2 diabetesThe role of Müller cells in tractional macular disorders: an optical coherence tomography study and physical model of mechanical force transmissionFoveal Abnormality associated with epiretinal Tissue of medium reflectivity and Increased blue-light fundus Autofluorescence Signal (FATIAS)
P50
Q27028225-39512E25-E539-4174-AC51-CF178550A3AFQ33401447-452C3C01-D526-4CD8-BCE5-1FDE38311204Q33513713-80434AAF-74FB-48E9-9781-64A365835288Q33820487-9E5BA99D-3939-400F-9C83-A2F26B543E3AQ34141176-52DCCD91-F411-4276-95DD-611351284D1FQ34269887-DE68311B-14D0-4CC4-B8EE-96FC2C46EB8BQ34419942-F36492E0-E292-4504-AFF3-74911727910EQ35051436-7B8506C5-A000-47F0-914E-67F71557F75BQ35820338-B985ADD2-0DDF-431C-BC30-26A7115BB30AQ36468115-86515B06-D83A-4D7B-BE40-940A7D9BCED2Q37292151-E91B57FF-4A27-4187-A21C-7578B70913F1Q38041365-57A4D46D-FCC9-409D-A830-6BEB4BCA4D8DQ38138477-D41AD090-C780-452F-B653-DF03FD39D56FQ38162433-D61FA92E-0435-4570-86AA-ABCDDB3FD621Q38542115-0372A4AC-62D7-4C3D-A37C-57F053FFDF97Q41023801-42248764-1A74-4551-964B-621204DCC2A3Q42772582-81A53935-73C2-4E38-892B-FC55738AB3BCQ43001263-3EBA3050-B0F6-4E64-A750-378FC2DE1E4FQ43228805-A0ADBE41-B1CC-4FD4-95A4-BAB27FCE25ABQ43411561-E82F9F52-D566-4D29-A4E2-0DB518340335Q45965061-E8C200E6-0402-4E32-AF73-4EFD96EC5FE0Q46117408-F20ABEF0-A174-4604-8E40-353F63322176Q46735946-6D9E97FE-1E18-455B-BE99-CD74E4E85EE7Q46849049-7199EAD4-222F-4ECE-A2E1-CC20D4DD4756Q46960470-56490B4F-3AF4-4D20-8116-25718BF2467DQ50667250-B3B7669F-838B-407A-93DA-002C181029DCQ51030485-50CBAE87-0ACE-4A89-B6F6-F24AD1FACA7AQ52620976-0772275B-11EF-43F3-9919-C8F66665CF24Q61041498-D582CE4D-005C-4A05-B931-4961AF4A265BQ80334529-5854932A-BAC8-4997-BAFF-827BE8B7BE15Q83814688-21C2C897-B5B0-4AC7-87F9-BEB8043B3FDCQ85005615-2FECD40E-D271-4042-BD80-E60823F7BE4BQ85274681-91FDBFBA-572F-4337-ACE8-1639D054BDE2Q86926744-2F9C2122-4EDA-4457-A6F7-B2035DC67050Q87986111-C06BC650-E052-4ADB-ACB2-B962BA3BD5B6Q87993568-EC3A23F2-2ACA-4C69-A911-8D9B83EB8669Q88564339-D2AC71E7-86EC-4CDF-B284-F62217E1F424Q89209548-A3654DF9-3495-48FC-9B6F-9B5F22883F49Q92050690-91C1B484-907C-491D-9101-15249D320260Q93173026-6F4A49C2-D75D-4008-BFDE-660A9C82FCE7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberto dell'Omo
@ast
Roberto dell'Omo
@en
Roberto dell'Omo
@es
Roberto dell'Omo
@nl
Roberto dell'Omo
@sl
type
label
Roberto dell'Omo
@ast
Roberto dell'Omo
@en
Roberto dell'Omo
@es
Roberto dell'Omo
@nl
Roberto dell'Omo
@sl
prefLabel
Roberto dell'Omo
@ast
Roberto dell'Omo
@en
Roberto dell'Omo
@es
Roberto dell'Omo
@nl
Roberto dell'Omo
@sl
P1053
K-7328-2016
P106
P1153
16041913800
P21
P31
P3829
P496
0000-0002-7663-8874